← back to search

Jonathan M. Woo

University of California, San Francisco · US
Area of research
Immunology · Molecular Biology
Research interest
Research interests include CRISPR and Genetic Engineering, T-cell and B-cell Immunology, Drug Transport and Resistance Mechanisms, and Immune Cell Function and Interaction.
h-index
16
citations
2,575
works
28
NIH funding
primary concept
email

Recent publications

A functional map of HIV-host interactions in primary human T cells
Nature Communications 2022cited by 52position: middledoi
XYZeq: Spatially resolved single-cell RNA sequencing reveals expression heterogeneity in the tumor microenvironment
Science Advances 2021cited by 116position: middledoi
Evaluation of SARS-CoV-2 serology assays reveals a range of test performance
Nature Biotechnology 2020cited by 299position: middledoi
CRISPR screen in regulatory T cells reveals modulators of Foxp3
Nature 2020cited by 233position: middledoi
Functional CRISPR dissection of gene networks controlling human regulatory T cell identity
Nature Immunology 2020cited by 92position: middledoi
Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function
Cell 2018cited by 557position: middledoi
Discovery of stimulation-responsive immune enhancers with CRISPR activation
Nature 2017cited by 318position: middledoi
A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells
Cell Reports 2016cited by 183position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Alexander Marson · UCSF Helen Diller Family Comprehensive Cancer Center6 papers (2016–2022)Eric Shifrut · Medical University of Graz5 papers (2018–2022)Theodore L. Roth · University of San Francisco5 papers (2018–2022)Victoria Tobin · California Institute of Technology2 papers (2018–2022)Nevan J. Krogan · QB32 papers (2016–2022)Jeffrey A. Bluestone · Fort Ross Conservancy2 papers (2020–2020)Kathrin Schumann · University of Konstanz2 papers (2016–2020)Dimitre R. Simeonov · University of California, San Francisco2 papers (2020–2020)Jennifer A. Doudna · QB32 papers (2016–2022)Jessica T. Cortez · Fundación para la Investigación, Docencia y Prevención del Cáncer2 papers (2020–2020)Judd F. Hultquist · Northwestern University2 papers (2016–2022)Chun Ye · University of California, San Francisco2 papers (2020–2021)Cody T. Mowery · University of California, San Francisco1 papers (2021–2021)Ruby Yu · Chinese University of Hong Kong1 papers (2020–2020)Frédéric Van Gool · Integrated BioTherapeutics (United States)1 papers (2020–2020)Jason A. Wojcechowskyj · QB31 papers (2022–2022)Julia Carnevale · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2018–2018)Harmit S. Malik · Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa1 papers (2022–2022)Yuanming Xu · UPMC Hillman Cancer Center1 papers (2020–2020)Deyu Fang · University of Arizona1 papers (2020–2020)